Skip to main content
Clinical Trials/NCT06510712
NCT06510712
Not yet recruiting
Not Applicable

Nutritional Risk and Health Research for Hospitalized Patients With Neurology Disorders in China

Xuanwu Hospital, Beijing0 sites10,000 target enrollmentSeptember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neurological Disorder
Sponsor
Xuanwu Hospital, Beijing
Enrollment
10000
Primary Endpoint
All-cause mortality
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Neurology disorders are one of the major public health problems that seriously threaten human health. It often accompanied by various nutritional problems, which can aggravate the primary disease, lead to serious complications, prolong the hospitalization, lead to poor prognosis, and increase family and social economic burdens. According to the previous studies, the risk of malnutrition was approximately 58.5% of stroke patients, and 6% had moderate to severe malnutrition in China. Another study conducted in Beijing showed that the risk of malnutrition of elderly patients in the department of neurology was significantly higher than in other departments (28.5% vs. 26.4%). Strengthening nutritional supervision of patients with neurology disorders will benefit to improve patients' prognosis. Therefore, the aim of this study is to investigate the nutritional status of inpatients with neurology disorders in China, evaluate the impact of different nutritional status on patients' health outcomes, and establish a high-quality, standardized nutrition and health cohort database for neurology disorders.

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
June 30, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years;
  • The primary diagnosis was neurological disorders;
  • Written informed consent.

Exclusion Criteria

  • Life expectancy is \< 3 months;
  • Researchers think other ineligible participant for the study.

Outcomes

Primary Outcomes

All-cause mortality

Time Frame: 30 days

Mortality defined as all-cause mortality from inclusion to day 30

Secondary Outcomes

  • Non-elective hospital readmission(30 days)
  • ICU admission(30 days)
  • Major complications(30 days)
  • length of in hospital days(30 days)
  • Decline in functional status of 10% or more(30 days)

Similar Trials